Contact
Please use this form to send email to PR contact of this press release:
Allena Pharmaceuticals Initiates First Phase 3 Trial for ALLN-177 in Patients with Enteric Hyperoxaluria
TO:
Please use this form to send email to PR contact of this press release:
Allena Pharmaceuticals Initiates First Phase 3 Trial for ALLN-177 in Patients with Enteric Hyperoxaluria
TO: